Non small cell lung cancer (NSCLC), Mesothelioma, Thymoma research hub

The effect of oral folinic acid rescue therapy on pemetrexed induced neutropenia and other toxicity: A randomized open-label trial.

This study is looking at a medicine called Rescuvolin to see if it can help reduce a common side effect of cancer treatment, called neutropenia. Neutropenia means you have too few white blood cells, which can make you more likely to get infections. We want to see if Rescuvolin can make this side effect less severe for people with certain cancers.